Clinical Trials Browser

Phase 2 × penpulimab × Gynecologic × Clear all

NCT05137171 2021-11-30

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms